Anti-arrhythmic effects of hypercalcemia in hyperkalemic, langendorff-perfused mouse hearts

Biomedical Reports

Volumn 5, Issue 3, 2016, Pages 301-310

  Tse, Gary ^a   Sun, Bing ^b   Wong, Sheung Ting ^c   Tse, Vivian ^d   Yeo, Jie Ming ^c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b TONGJI HOSPITAL OF TONGJI UNIVERSITY   (China)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Action potential duration; Hypercalcemia; Hyperkalemia; Ventricular arrhythmia

Indexed keywords

ANTIARRHYTHMIC ACTIVITY; APD90; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; HEART MUSCLE REFRACTORY PERIOD; HEART VENTRICLE TACHYCARDIA; HYPERCALCEMIA; HYPERKALEMIA; ISOLATED HEART; MOUSE; NONHUMAN; REPOLARIZATION;

EID: 85046236178     PISSN: 20499434     EISSN: 20499442     Source Type: Journal    
DOI: 10.3892/br.2016.735     Document Type: Article

References (93)

1. No authors listed: Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 8: Advanced challenges in resuscitation: section 1: Life-threatening electrolyte abnormalities. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation 102 (Suppl 8): I217-I222, 2000.
2. Gettes LS: Electrolyte abnormalities underlying lethal and ventricular arrhythmias. Circulation 85 (Suppl 1): I70-I76, 1992
3. Friedensohn A, Faibel HE, Bairey O, Goldbourt U and Schlesinger Z: Malignant arrhythmias in relation to values of serum potassium in patients with acute myocardial infarction. Int J Cardiol 32: 331-338, 1991.
4. Ahmed MI, Ekundayo OJ, Mujib M, Campbell RC, Sanders PW, Pitt B, Perry GJ, Bakris G, Aban I, Love TE, et al: Mild hyperkalemia and outcomes in chronic heart failure: A propensity matched study. Int J Cardiol 144: 383-388, 2010.
5. Bashour TT and Cheng TO: Evidence for specialized atrioventricular conduction in hyperkalemia. J Electrocardiol 8: 65-68, 1975.
6. Dittrich KL and Walls RM: Hyperkalemia: ECG manifestations and clinical considerations. J Emerg Med 4: 449-455, 1986.
7. Freeman K, Feldman JA, Mitchell P, Donovan J, Dyer KS, Eliseo L, White LF and Temin ES: Effects of presentation and electrocardiogram on time to treatment of hyperkalemia. Acad Emerg Med 15: 239-249, 2008.
8. Cooper WD, Kuan P, Reuben SR and VandenBurg MJ: Cardiac arrhythmias following acute myocardial infarction: Associations with the serum potassium level and prior diuretic therapy. Eur Heart J 5: 464-469, 1984.
9. Weiner ID and Wingo CS: Hyperkalemia: A potential silent killer. J Am Soc Nephrol 9: 1535-1543, 1998.
10. Sood MM and Pauly RP: A case of severe hyperkalemia: Fast, safe and effective treatment is required. J Crit Care 23: 431-433, 2008.
11. Kiewiet RM, Ponssen HH, Janssens EN and Fels PW: Ventricular fibrillation in hypercalcaemic crisis due to primary hyperparathyroidism. Neth J Med 62: 94-96, 2004.
12. Curione M, Letizia C, Amato S, Di Bona S, Di Fazio F, Minisola S, Mazzuoli G and D'Erasmo E: Increased risk of cardiac death in primary hyperparathyroidism: What is a role of electrical instability? Int J Cardiol 121: 200-202, 2007.
13. George SA, Sciuto KJ, Lin J, Salama ME, Keener JP, Gourdie RG and Poelzing S: Extracellular sodium and potassium levels modulate cardiac conduction in mice heterozygous null for the Connexin43 gene. Pflugers Arch 467: 2287-2297, 2015.
14. Kodama I, Wilde A, Janse MJ, Durrer D and Yamada K: Combined effects of hypoxia, hyperkalemia and acidosis on membrane action potential and excitability of guinea-pig ventricular muscle. J Mol Cell Cardiol 16: 247-259, 1984.
15. Leitch SP and Paterson DJ: Role of Ca2+ in protecting the heart from hyperkalemia and acidosis in the rabbit: Implications for exercise. J Appl Physiol (1985) 77: 2391-2399, 1994.
16. Piktel JS, Wan X, Infeld M, Rosenbaum D and Wilson LD: Beneficial effect of calcium treatment for hyperkalemia is mediated by calcium-dependent conduction, not ‘membrane stabilization’. Ann Emerg Med 56: S9, 2010.
17. Tse G and Yeo JM: Conduction abnormalities and ventricular arrhythmogenesis: The roles of sodium channels and gap junctions. Int J Cardiol Heart Vasc 9: 75-82, 2015.
18. Choy L, Yeo JM, Tse V, Chan SP and Tse G: Cardiac disease and arrhythmogenesis: Mechanistic insights from mouse models. Int J Cardiol Heart Vasc 12: 1-10, 2016.
19. Tse G: Both transmural dispersion of repolarization and transmural dispersion of refractoriness are poor predictors of arrhythmogenicity: A role for the index of Cardiac Electrophysiological Balance (QT/QRS)? J Geriatr Cardiol (In press)
20. Tse G, Lai ET, Yeo JM and Yan BP: Electrophysiological mechanisms of Bayés syndrome: Insights from clinical and mouse studies. Front Physiol: May 31, 2016 (Epub ahead of print).
21. Tse G, Lai ET, Lee AP, Yan BP and Wong SH: Electrophysiological mechanisms of gastrointestinal arrhythmogenesis: Lessons from the heart. Front Physiol (In press).
22. Tse G, Lai TH, Yeo JM, Tse V and Wong SH: Mechanisms of electrical activation and conduction in the gastrointestinal system: Lessons from cardiac electrophysiology. Front Physiol: May 31, 2016 (Epub ahead of print).
23. Tse G, Lai ET, Tse V and Yeo JM: Molecular and electrophysiological mechanisms underlying cardiac arrhythmogenesis in diabetes mellitus. J Diabetes Res (In press).
24. Tse G and Yan BP: Novel arrhythmic risk markers incorporating QRS dispersion: QRSd x (Tpeak-Tend)/QRS and QRSdx (Tpeak-Tend)/(QTxQRS). AnnNoninvasiveElectrocardiol (In press).
25. Tse G: Novel conduction-repolarization indices for the stratification of arrhythmic risk. J Geriatr Cardiol (In press).
26. Tse G: (Tpeak-Tend)/QRS and (Tpeak-Tend)/(QT x QRS): Novel markers for predicting arrhythmic risk in Brugada syndrome. Europace (In press)
27. Tse G, Wong ST, Tse V, Lee YT, Lin HY and Yeo JM: Cardiac dynamics: alternans and arrhythmogenesis. J Arrhythm: Mar 28, 2016 (Epub ahead of print).
28. Tse G: Mechanisms of cardiac arrhythmias. J Arrhythm 32: 75-81, 2016.
29. Tse G, Tse V and Yeo JM: Ventricular anti-arrhythmic effects of heptanol in hypokalaemic, Langendorff-perfused mouse hearts. Biomed Rep 4: 313-324, 2016.
30. Tse G, Wong ST, Tse V and Yeo JM: Restitution analysis of alternans using dynamic pacing and its comparison with S1S2 restitution in heptanol-treated, hypokalaemic Langendorff-perfused mouse hearts. Biomed Rep 4: 673-680, 2016.
31. Tse G, Hothi SS, Grace AA and Huang CL: Ventricular arrhythmogenesis following slowed conduction in heptanol-treated, Langendorff-perfused mouse hearts. J Physiol Sci 62: 79-92, 2012.
32. Tse G, Tse V, Yeo JM and Sun B: Atrial anti-arrhythmic effects of heptanol in Langendorff-perfused mouse hearts. PLoS One 11: e0148858, 2016.
33. Hogan PM and Spitzer KW: Manganese amd electrogenic phenomena in canine Purkinje fibers. Circ Res 36: 377-391, 1975.
34. Balasubramaniam R, Chawla S, Mackenzie L, Schwiening CJ, Grace AA and Huang CL: Nifedipine and diltiazem suppress ventricular arrhythmogenesis and calcium release in mouse hearts. Pflugers Arch 449: 150-158, 2004.
35. Balasubramaniam R, Grace AA, Saumarez RC, Vandenberg JI and Huang CL: Electrogram prolongation and nifedipine-suppressible ventricular arrhythmias in mice following targeted disruption of KCNE1. J Physiol 552: 535-546, 2003.
36. Head CE, Balasubramaniam R, Thomas G, Goddard CA, Lei M, Colledge WH, Grace AA and Huang CL: Paced electrogram fractionation analysis of arrhythmogenic tendency in DeltaKPQ Scn5a mice. J Cardiovasc Electrophysiol 16: 1329-1340, 2005.
37. Knollmann BC, Katchman AN and Franz MR: Monophasic action potential recordings from intact mouse heart: Validation, regional heterogeneity, and relation to refractoriness. J Cardiovasc Electrophysiol 12: 1286-1294, 2001.
38. Gussak I, Chaitman BR, Kopecky SL and Nerbonne JM: Rapid ventricular repolarization in rodents: Electrocardiographic manifestations, molecular mechanisms, and clinical insights. J Electrocardiol 33: 159-170, 2000.
39. Fabritz L, Kirchhof P, Franz MR, Eckardt L, Mönnig G, Milberg P, Breithardt G and Haverkamp W: Prolonged action potential durations, increased dispersion of repolarization, and polymorphic ventricular tachycardia in a mouse model of proarrhythmia. Basic Res Cardiol 98: 25-32, 2003.
40. Sabir IN, Fraser JA, Killeen MJ, Grace AA and Huang CL: The contribution of refractoriness to arrhythmic substrate in hypokalemic Langendorff-perfused murine hearts. Pflugers Arch 454: 209-222, 2007.
41. Kléber AG and Rudy Y: Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev 84: 431-488, 2004.
42. Thomas GP, Howlett SE and Ferrier GR: Saralasin suppresses arrhythmias in an isolated guinea pig ventricular free wall model of simulated ischemia and reperfusion. J Pharmacol Exp Ther 274: 1379-1386, 1995.
43. Nolan JP, Soar J, Zideman DA, Biarent D, Bossaert LL, Deakin C, Koster RW, Wyllie J and Böttiger B; ERC Guidelines Writing Group: European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary. Resuscitation 81: 1219-1276, 2010.
44. Tse G, Wong ST, Tse V and Yeo JM: Depolarization vs. repolarization: What is the mechanism of ventricular arrhythmogenesis underlying sodium channel haploinsufficiency in mouse hearts? Acta Physiol (Oxf): Apr 30, 2016.
45. Chen Z, Sun B, Tse G, Jiang J and Xu W: Reversibility of both sinus node dysfunction and reduced HCN4 mRNA expression level in an atrial tachycardia pacing model of tachycardia-bradycardia syndrome in rabbit hearts. Int J Clin Exp Pathol (In press).
46. Tse G, Wong ST, Tse V and Yeo JM: Determination of action potential wavelength restitution in Scn5a +/− mouse hearts modelling human Brugada syndrome. J Physiol (In press).
47. Antzelevitch C: Cellular basis for the repolarization waves of the ECG. Ann N Y Acad Sci 1080: 268-281, 2006.
48. Fisch C: Relation of electrolyte disturbances to cardiac arrhythmias. Circulation 47: 408-419, 1973.
49. Sanguinetti MC and Jurkiewicz NK: Role of external Ca2+ and K+ in gating of cardiac delayed rectifier K+ currents. Pflugers Arch 420: 180-186, 1992.
50. Sanguinetti MC, Jiang C, Curran ME and Keating MT: A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 81: 299-307, 1995.
51. Kishida H, Surawicz B and Fu LT: Effects of K+ and K+-induced polarization on (dV/dt)max, threshold potential, and membrane input resistance in guinea pig and cat ventricular myocardium. Circ Res 44: 800-814, 1979.
52. Dominguez G and Fozzard HA: Influence of extracellular K+ concentration on cable properties and excitability of sheep cardiac Purkinje fibers. Circ Res 26: 565-574, 1970.
53. Ettinger PO, Regan TJ and Oldewurtel HA: Hyperkalemia, cardiac conduction, and the electrocardiogram: A review. Am Heart J 88: 360-371, 1974.
54. Killeen MJ, Thomas G, Gurung IS, Goddard CA, Fraser JA, Mahaut-Smith MP, Colledge WH, Grace AA and Huang CL: Arrhythmogenic mechanisms in the isolated perfused hypokalaemic murine heart. Acta Physiol (Oxf) 189: 33-46, 2007.
55. Nerbonne JM and Guo W: Heterogeneous expression of voltage-gated potassium channels in the heart: Roles in normal excitation and arrhythmias. J Cardiovasc Electrophysiol 13: 406-409, 2002.
56. Antzelevitch C: Transmural dispersion of repolarization and the T wave. Cardiovasc Res 50: 426-431, 2001.
57. Yan GX and Martin J: Electrocardiographic T wave: A symbol of transmural dispersion of repolarization in the ventricles. J Cardiovasc Electrophysiol 14: 639-640, 2003.
58. Mines GR: On dynamic equilibrium in the heart. J Physiol 46: 349-383, 1913.
59. Weidmann S: Effects of calcium ions and local anesthetics on electrical properties of Purkinje fibres. J Physiol 129: 568-582, 1955.
60. Hélie F, Cossette J, Vermeulen M and Cardinal R: Differential effects of lignocaine and hypercalcaemia on anisotropic conduction and reentry in the ischaemically damaged canine ventricle. Cardiovasc Res 29: 359-372, 1995.
61. Corlew DS, Bryda SL, Bradley EL III and DiGirolamo M: Observations on the course of untreated primary hyperparathyroidism. Surgery 98: 1064-1071, 1985.
62. Rosenqvist M, Nordenström J, Andersson M and Edhag OK: Cardiac conduction in patients with hypercalcaemia due to primary hyperparathyroidism. Clin Endocrinol (Oxf) 37: 29-33, 1992.
63. Parham WA, Mehdirad AA, Biermann KM and Fredman CS: Hyperkalemia revisited. Tex Heart Inst J 33: 40-47, 2006.
64. Rumancik WM, Denlinger JK, Nahrwold ML and Falk RB Jr.: The QT interval and serum ionized calcium. JAMA 240: 366-368, 1978.
65. Scheidegger D and Drop LJ: The relationship between duration of Q-T interval and plasma ionized calcium concentration: Experiments with acute, steady-state [Ca++] changes in the dog. Anesthesiology 51: 143-148, 1979.
66. Wortsman J and Frank S: The QT interval in clinical hypercalcemia. Clin Cardiol 4: 87-90, 1981.
67. Killeen MJ, Thomas G, Sabir IN, Grace AA and Huang CL: Mouse models of ventricular arrhythmias. Acta Physiol (Oxf) 192: 455-469, 2008.
68. Nerbonne JM and Kass RS: Molecular physiology of cardiac repolarization. Physiol Rev 85: 1205-1253, 2005.
69. Hsieh YC, Lin JC, Hung CY, Li CH, Lin SF, Yeh HI, Huang JL, Lo CP, Haugan K, Larsen BD, et al: Gap junction modifier rotigaptide decreases the susceptibility to ventricular arrhythmia by enhancing conduction velocity and suppressing discordant alternans during therapeutic hypothermia in isolated rabbit hearts. Heart Rhythm 13: 251-261, 2016.
70. Wu TJ, Lin SF, Weiss JN, Ting CT and Chen PS: Two types of ventricular fibrillation in isolated rabbit hearts: Importance of excitability and action potential duration restitution. Circulation 106: 1859-1866, 2002.
71. Osadchii OE: Effects of ventricular pacing protocol on electrical restitution assessments in guinea-pig heart. Exp Physiol 97: 807-821, 2012.
72. Osadchii OE, Larsen AP and Olesen SP: Predictive value of electrical restitution in hypokalemia-induced ventricular arrhythmogenicity. Am J Physiol Heart Circ Physiol 298: H210-H220, 2010.
73. Osadchii OE: Mechanisms of hypokalemia-induced ventricular arrhythmogenicity. Fundam Clin Pharmacol 24: 547-559, 2010.
74. Osadchii OE, Bentzen BH and Olesen SP: Chamber-specific effects of hypokalaemia on ventricular arrhythmogenicity in isolated, perfused guinea-pig heart. Exp Physiol 94: 434-446, 2009.
75. Osadchii OE and Olesen SP: Electrophysiological determinants of hypokalaemia-induced arrhythmogenicity in the guinea-pig heart. Acta Physiol (Oxf) 197: 273-287, 2009.
76. Osadchii OE: Flecainide attenuates rate adaptation of ventricular repolarization in guinea-pig heart. Scand Cardiovasc J 50: 28-35, 2016.
77. Osadchii OE: Impact of hypokalemia on electromechanical window, excitation wavelength and repolarization gradients in guinea-pig and rabbit hearts. PLoS One 9: e105599, 2014.
78. Osadchii OE: Impaired epicardial activation-repolarization coupling contributes to the proarrhythmic effects of hypokalaemia and dofetilide in guinea pig ventricles. Acta Physiol (Oxf) 211: 48-60, 2014.
79. Osadchii OE: Flecainide-induced proarrhythmia is attributed to abnormal changes in repolarization and refractoriness in perfused guinea-pig heart. J Cardiovasc Pharmacol 60: 456-466, 2012.
80. Hsieh YC, Lin SF, Lin TC, Ting CT and Wu TJ: Therapeutic hypothermia (30 degrees C) enhances arrhythmogenic substrates, including spatially discordant alternans, and facilitates pacing-induced ventricular fibrillation in isolated rabbit hearts. Circ J 73: 2214-2222, 2009.
81. Franz MR, Burkhoff D, Spurgeon H, Weisfeldt ML and Lakatta EG: In vitro validation of a new cardiac catheter technique for recording monophasic action potentials. Eur Heart J 7: 34-41, 1986.
82. Hoffman BF, Cranefield PF, Lepeschkin E, Surawicz B and Herrlich HC: Comparison of cardiac monophasic action potentials recorded by intracellular and suction electrodes. Am J Physiol 196: 1297-1301, 1959.
83. Tse G, Wong ST, Tse V, Yeo JM, Lin HY and Yeo JM: Monophasic action potential recordings: Which is the recording electrode? J Basic Clin Physiol Pharmacol: Apr 30, 2016 (Epub ahead of print).
84. Tse G, Ali A, Alpendurada F, Prasad S, Raphael CE and Vassiliou V: Tuberculous Constrictive Pericarditis. Res Cardiovasc Med 4: e29614, 2015.
85. Tse G, Ali A, Prasad SK, Vassiliou V and Raphael CE: Atypical case of post-partum cardiomyopathy: an overlap syndrome with arrhythmogenic right ventricular cardiomyopathy? BJR|case reports 1: 20150182, 2015.
86. Vassiliou V, Chin C, Perperoglou A, Tse G, Ali A, Raphael C, Jabbour A, Newby D, Pennell D, Dweck M and Prasad S: 93 Ejection Fraction by Cardiovascular Magnetic Resonance Predicts Adverse Outcomes Post Aortic Valve Replacement. Heart 100 (Suppl 3): A53-A54, 2014.
87. Kwong JS, Leithäuser B, Park JW and Yu CM: Diagnostic value of magnetocardiography in coronary artery disease and cardiac arrhythmias: A review of clinical data. Int J Cardiol 167: 1835-1842, 2013.
88. Steinhoff U, Knappe-Grueneberg S, Schnabel A, Trahms L, Smith F, Langley P, Murray A and Koch H: Magnetocardiography for pharmacology safety studies requiring high patient throughput and reliability. J Electrocardiol 37: 187-192, 2004.
89. Yoshida K, Ogata K, Inaba T, Nakazawa Y, Ito Y, Yamaguchi I, Kandori A and Aonuma K: Ability of magnetocardiography to detect regional dominant frequencies of atrial fibrillation. J Arrhythm 31: 345-351, 2015.
90. Ito Y, Shiga K, Yoshida K, Ogata K, Kandori A, Inaba T, Nakazawa Y, Sekiguchi Y, Tada H, Sekihara K, et al: Development of a magnetocardiography-based algorithm for discrimination between ventricular arrhythmias originating from the right ventricular outflow tract and those originating from the aortic sinus cusp: A pilot study. Heart Rhythm 11: 1605-1612, 2014.
91. Sato Y, Yoshida K, Ogata K, Inaba T, Tada H, Sekiguchi Y, Ito Y, Ishizu T, Seo Y, Yamaguchi I, et al: An increase in right atrial magnetic strength is a novel predictor of recurrence of atrial fibrillation after radiofrequency catheter ablation. Circ J 76: 1601-1608, 2012.
92. Tse G, Wong ST, Tse V and Yeo JM: Variability in local action potential durations, dispersion of repolarization and wavelength restitution in aged wild-type and Scn5a+/− mouse hearts modelling human Brugada syndrome. Journal of Geriatric Cardiology (In press).
93. Tse G, Yeo JM, Tse V and Sun B: Gap junction inhibition by heptanol increases ventricular arrhythmogenicity by decreasing conduction velocity without affecting repolarization properties or myocardial refractoriness in Langendorff-perfused mouse hearts. MMR (In press)